Deluxe Family Co., Ltd.

Equities

600503

CNE000001BT2

Real Estate Development & Operations

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
2.04 CNY +2.00% Intraday chart for Deluxe Family Co., Ltd. +4.08% -20.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Deluxe Family Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Deluxe Family's Second-Largest Shareholder Vetoes Proposals at Board Meeting MT
Deluxe Family Clarifies Shareholder Proposal Dispute Amid Frozen Equity Issue; Shares Up 5% MT
Deluxe Family Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Huatai Securities Co., Ltd. completed the acquisition of remaining 40% stake in Huatai Futures Co., Ltd. from Deluxe Family Co., Ltd.. CI
Investors in Futures Brokers in China Sell Stakes as COVID-19 Dents Profits MT
Shanghai Origincell Biological Cryo Equipment Co., Ltd. announced that it has received CNY 410.464 million in funding from a group of investors CI
Huatai Securities Co., Ltd. entered into an agreement to acquire remaining 40% stake in Huatai Futures Co., Ltd. from Deluxe Family Co., Ltd. for CNY 1.59 billion. CI
Deluxe Family Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shanghai Origincell Biological Cryo Equipment Co., Ltd. announced that it expects to receive CNY 410.464 million in funding from a group of investors CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Shanghai Origincell Biological Cryo Equipment Co., Ltd. announced that it expects to receive CNY 342.44 million in funding from a group of investors CI
Lishui Haitai Real Estate Co., Ltd. signed an equity transfer agreement to acquire 15.71% stake in Shanghai Rehabilitation Biotechnology Co., Ltd. from Deluxe Family Co., Ltd. for CNY 40 million. CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Deluxe Family Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Deluxe Family Co., Ltd. Announces Cash Dividend for 2019, Payable July 10, 2020 CI
Chart Deluxe Family Co., Ltd.
More charts
Deluxe Family Co., Ltd. is a China-based company principally engaged in the real estate related businesses. The Company’s real estate businesses mainly include the development, construction, sales and leasing of residential and office buildings, as well as parking lots. The Company is also engaged in the construction and decoration business, machinery manufacturing and non-metallic mineral product business. The Company is also involved in the investment in innovative technology and financial projects through its subsidiaries, including the graphene, space vehicle, intelligent robot and biomedical projects.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 600503 Stock
  4. News Deluxe Family Co., Ltd.
  5. Deluxe Family's Second-Largest Shareholder Vetoes Proposals at Board Meeting